MedTrace Logo

Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT

NCT02963129 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-11-15

No results posted yet for this study

Summary

Compare the frequency of epistaxis and quality of life related to nasal bleeding in patients with HHT colonized with sataphylococo before and after being treated with mupirocin ointment.

Conditions

  • Hereditary Hemorrhagic Telangiectasia
  • Epistaxis

Interventions

DRUG

Mupirocin

Mupirocin ointment in the nose for 5 days

OTHER

Placebo

Placebo ointment in the nose for 5 days

Sponsors & Collaborators

  • Hospital Italiano de Buenos Aires

    lead OTHER

Principal Investigators

  • Marcelo MS Serra, MD · Staff of the Department of Clinical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-30
Primary Completion
2017-06-30
Completion
2017-12-31

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02963129 on ClinicalTrials.gov